Novos general counsel John Kuckelman told CNBC it may have been accurate for Lilly to boast about Zepbounds greater efficacy before the 7.2 milligram dose of Wegovy became available, but it is no longer accurate to say that. Novos suit says Lilly acknowledges a higher dose of Wegovy in a brief footnote in the television ad, but it says the footnote is ambiguous, confusing, virtually illegible, and wholly inadequate. key background Novo Nordisk and Eli Lilly, chief rivals in the booming GLP-1 industry, have struggled for dominance over the obesity medication market, with Novos market share slipping from an early lead
You know thats required
The number of injections depends on individual goals
But Semaglutide is a new generation of highly effective hormone-based obesity medications
By helping to manage appetite and food cravings, Mounjaro can free up mental energy and make adhering to healthier eating patterns more achievable
"I looked at it as a sport, as an opponent," she said